Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of GYPA recombinant monoclonal antibody, clone GYPA/1725R
| Brand | Abnova |
| Reactivity | Human |
| Applications | IHC-P,IF,Flow Cyt |
More info about GYPA recombinant monoclonal antibody, clone GYPA/1725R
| Brand: | Abnova |
| Reference: | RAB00330 |
| Product name: | GYPA recombinant monoclonal antibody, clone GYPA/1725R |
| Product description: | Recombinant rabbit monoclonal antibody raised against human GYPA. |
| Clone: | GYPA/1725R |
| Isotype: | IgG, kappa |
| Gene id: | 2993 |
| Gene name: | GYPA |
| Gene alias: | CD235a|GPA|GPErik|GPSAT|GpMiIII|HGpMiIII|HGpMiV|HGpMiX|HGpMiXI|HGpSta(C)|MN|MNS |
| Gene description: | glycophorin A (MNS blood group) |
| Immunogen: | Original antibody is raised against recombinant protein corresponding to full length human GYPA. |
| Protein accession: | P02724 |
| Form: | Liquid |
| Recommend dilutions: | Flow Cytometry (0.5-1 ug/106 cells) Immunofluorescence (0.5-1 ug/mL) Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) (0.25-0.5 ug/mL) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In 10 mM PBS. |
| Storage instruction: | Store at -20 to -80°C. Aliquot to avoid repeated freezing and thawing. |
| Antigen species / target species: | Human |
| Reactivity: | Human |
| Application image: |  |
| Application image note: | Immunohistochemical staining (Formalin-fixed paraffin-embedded sections) of human angiosarcoma with GYPA recombinant monoclonal antibody, clone GYPA/1725R (Cat # RAB00330). |
| Applications: | IHC-P,IF,Flow Cyt |
| Shipping condition: | Dry Ice |
| Publications: | Glycophorin A expression in malignant hematopoiesis.Liszka K, Majdic O, Bettelheim P, Knapp W. Am J Hematol. 1983 Nov;15(3):219-26. |